Cambrex to Announce Second Quarter 2016 Financial Results on July 28, 2016
EAST RUTHERFORD, N.J., July 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) announced that second quarter 2016 financial results will be released on Thursday, July 28, 2016 before the market opens.
The Company will host a conference call to discuss the financial results.
| Second Quarter 2016 Earnings Conference Call | ||||||||||||||||||
| When: | Thursday, July 28, 2016 at 8:30 a.m. Eastern Time | |||||||||||||||||
| Dial-in: | 1-844-244-1943 for U.S. | |||||||||||||||||
| 1-513-988-8630 for International | ||||||||||||||||||
| Passcode: 56378506 | ||||||||||||||||||
| Dial-in Replay: | 1-855-859-2056 for U.S. | |||||||||||||||||
| 1-404-537-3406 for International | ||||||||||||||||||
| Passcode: 56378506 | ||||||||||||||||||
| Available through Thursday, August 4, 2016 | ||||||||||||||||||
| Webcast: | www.cambrex.com | |||||||||||||||||
About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Phone: 201.804.3037 Email: stephanie.lafiura@cambrex.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
